Can Ativan (lorazepam) be used to treat pseudoseizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ativan Should NOT Be Used for Pseudoseizures

Lorazepam (Ativan) is indicated for true epileptic seizures, not pseudoseizures (psychogenic non-epileptic seizures). Administering benzodiazepines to patients with pseudoseizures provides no therapeutic benefit, exposes patients to unnecessary risks including respiratory depression and sedation, and may reinforce illness behavior while delaying appropriate psychiatric treatment.

Understanding the Critical Distinction

Pseudoseizures, more appropriately termed psychogenic non-epileptic seizures (PNES), are paroxysmal events that resemble epileptic seizures but lack the abnormal electrical brain activity that characterizes true seizures. The 2014 ACEP guidelines explicitly acknowledge this diagnostic challenge, noting that "a variety of clinical conditions may lead to events that resemble convulsive seizures but in fact are not," including psychogenic nonepileptic seizures 1.

Why Benzodiazepines Are Inappropriate for PNES

  • No physiological mechanism of action: Benzodiazepines work by enhancing GABA activity to suppress excessive synchronous cortical electrical activity 2. Since PNES lacks this electrical activity, there is no biological substrate for lorazepam to act upon.

  • Iatrogenic harm: Lorazepam carries significant risks including respiratory depression (requiring immediate airway management equipment per FDA labeling 3), sedation, paradoxical agitation (10% in adults, 10-30% in pediatric patients) 3, and vital instability. Recent evidence demonstrates that even in true seizures lasting <5 minutes, lorazepam administration significantly increases vital instability (OR = 6.76) and ICU length of stay 4.

  • Reinforcement of maladaptive behavior: Administering medication for PNES may inadvertently validate and reinforce the seizure-like behavior, making psychiatric treatment more difficult.

The Correct Approach to PNES

The appropriate treatment for PNES is psychological intervention, specifically cognitive behavioral therapy (CBT), not pharmacological management. The WHO guidelines explicitly recommend "psychological treatment based on CBT principles should be considered in repeat adult help seekers with medically unexplained somatic complaints who are in substantial distress" 2. This directly applies to PNES, which falls under the category of medically unexplained neurological symptoms.

Clinical Algorithm for Management

  1. Establish the diagnosis: Video-EEG monitoring is the gold standard for distinguishing PNES from epileptic seizures. Clinical features suggestive of PNES include prolonged duration (>2 minutes), gradual onset, side-to-side head movements, pelvic thrusting, eye closure during events, and lack of postictal confusion.

  2. Avoid benzodiazepine administration: Do not give lorazepam or other benzodiazepines during suspected PNES events.

  3. Provide supportive care: Ensure patient safety during the event without physical restraint. Allow the episode to resolve spontaneously.

  4. Refer for psychiatric evaluation: Arrange consultation with psychiatry or psychology for CBT-based interventions, which are the evidence-based treatment for PNES 2.

  5. Address comorbidities: Screen for and treat underlying depression, anxiety, PTSD, or history of trauma, which commonly coexist with PNES.

Critical Pitfalls to Avoid

The most dangerous pitfall is misdiagnosing true status epilepticus as PNES, which would result in withholding life-saving benzodiazepine therapy. When diagnostic uncertainty exists in an acute setting:

  • If the patient has known epilepsy or the clinical presentation strongly suggests true seizures, treat as status epilepticus with IV lorazepam (4 mg for adults, preferred over diazepam) 2, 5.

  • If PNES is suspected but cannot be confirmed, prioritize patient safety by treating as true seizures until video-EEG can clarify the diagnosis.

  • The FDA-approved indication for lorazepam in status epilepticus is clear: 4 mg IV given slowly (2 mg/min), with repeat dosing after 10-15 minutes if seizures continue 3. This applies only to true epileptic seizures.

The converse error—treating confirmed PNES with benzodiazepines—causes harm without benefit and should be avoided once the diagnosis is established.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.